MCKESSON

McKesson Corporation is a leading global healthcare company specializing in the distribution of pharmaceuticals, medical supplies, and health information technology solutions. Established in 1833, McKesson has become one of the largest pharmaceutical distributors in North America. It delivers a significant portion of the medications used across the continent.

Product and Service Offerings

McKesson operates through several key segments:

• U.S. Pharmaceutical: Distributes a comprehensive range of pharmaceutical products, including branded, generic, specialty, biosimilar, and over-the-counter drugs. It offers practice management, technology, clinical support, and business solutions to community-based oncology and specialty practices. This segment also provides financial, operational, and clinical solutions to pharmacies along with consulting and outsourcing services.
• Medical-Surgical Solutions: Supplies medical-surgical products, pharmaceuticals, and laboratory equipment to non-acute care settings such as physician offices, surgery centers, long-term care providers, laboratories, home health and hospice agencies, health systems, government facilities, and online marketplaces. Offers over 285,000 national brand products, plus its own line of high-quality products through U.S. distribution centers.
• Prescription Technology Solutions (RxTS): Addresses medication access, affordability, and adherence challenges by connecting patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Offers prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support.
• International: Provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. In Canada, partners with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services that make quality care more accessible and affordable, including specialty healthcare, banner support programs, and technology solutions.

Recent Developments

In August 2024, McKesson announced acquiring a controlling 70% stake in Core Ventures, a business and administrative services unit of Florida Cancer Specialists & Research Institute (FCS), for $2.49 billion in cash. This acquisition diversifies McKesson’s specialty services, including branded, specialty, and generic drugs distribution and physician management services.

FCS operates nearly 100 locations across Florida with more than 250 physicians and 280 nurses and physician assistants.

Global Presence

McKesson's global footprint includes operations in North America, Europe, and Canada. The company has a significant presence in the United States with distribution centers and offices across all 50 states.

Locations in the U.S. include:

• Boulder, CO
• Loveland, CO
• Denver, CO
• Kansas City, MO
• Columbus, OH
• East Orange, NJ
• Norman, OK
• Portland, OR
• New York, NY
• Memphis, TN
• Irving, TX
• Oak Park, IL

In Canada, McKesson operates McKesson Canada and holds equity in Nadro, a major distributor in Mexico.

Through a diverse range of products and services, McKesson plays a crucial role in the healthcare supply chain, ensuring timely and efficient delivery of medical products and services to healthcare providers and patients worldwide.